Anesthesiology and Pain Medicine

Published by: Kowsar

Prolotherapy and Low Level Laser Therapy: A Synergistic Approach to Pain Management in Chronic Osteoarthritis

Vinicius Tieppo Francio 1 , 2 , 3 , * , Robert S Dima 4 , Chris Towery 1 and Saeid Davani 1
Authors Information
1 University of Science, Arts and Technology - USAT College of Medicine, Olveston, Montserrat, BWI
2 Essential Integrative Health - Spine, Orthopaedics and Pain Management, Oklahoma City, OK, USA
3 Variety Care - Community Health Center, Oklahoma City, OK, USA
4 School of Interdisciplinary Sciences - McMaster University, Hamilton, ON, Canada
Article information
  • Anesthesiology and Pain Medicine: October 2017, 7 (5); e14470
  • Published Online: October 15, 2017
  • Article Type: Review Article
  • Received: January 17, 2017
  • Revised: June 2, 2017
  • Accepted: October 9, 2017
  • DOI: 10.5812/aapm.14470

To Cite: Tieppo Francio V, Dima R S, Towery C, Davani S. Prolotherapy and Low Level Laser Therapy: A Synergistic Approach to Pain Management in Chronic Osteoarthritis, Anesth Pain Med. 2017 ; 7(5):e14470. doi: 10.5812/aapm.14470.

Abstract
Copyright © 2017, Anesthesiology and Pain Medicine. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Discussion
Footnote
References
  • 1. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008; 58(1): 26-35[DOI][PubMed]
  • 2. Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT, Sullivan MD, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009; 18(12): 1166-75[DOI][PubMed]
  • 3. Walker JM, Farney RJ, Rhondeau SM, Boyle KM, Valentine K, Cloward TV, et al. Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. J Clin Sleep Med. 2007; 3(5): 455-61[PubMed]
  • 4. Arden N, Blanco F, Cooper C, Guermazi A, Hayashi D, Hunter D, et al. Atlas of Osteoarthritis. 2014; [DOI]
  • 5. Hauser RA, Hauser MA, Baird NM, Martin DJ. Prolotherapy: an alternative to knee surgery. Journal of Prolotherapy . 2010; 2(1): 272-81
  • 6. Distel LM, Best TM. Prolotherapy: a clinical review of its role in treating chronic musculoskeletal pain. PM R. 2011; 3(6 Suppl 1)-81[DOI][PubMed]
  • 7. Rabago D, Slattengren A, Zgierska A. Prolotherapy in primary care practice. Prim Care. 2010; 37(1): 65-80[DOI][PubMed]
  • 8. Alderman DD, Alexander R. Advances in regenerative medicine: high-density platelet-rich plasma and stem cell prolotherapy for musculoskeletal pain. Pract Pain Manag. 2011; 11(8)
  • 9. Shallenberger F. ProlozoneTM-regenerating joints and eliminating pain. J Prolo. 2011; 3(2): 630-8
  • 10. Bjordal JM, Couppe C, Chow RT, Tuner J, Ljunggren EA. A systematic review of low level laser therapy with location-specific doses for pain from chronic joint disorders. Aust J Physiother. 2003; 49(2): 107-16[DOI][PubMed]
  • 11. Medrado AR, Pugliese LS, Reis SR, Andrade ZA. Influence of low level laser therapy on wound healing and its biological action upon myofibroblasts. Lasers Surg Med. 2003; 32(3): 239-44[DOI][PubMed]
  • 12. Chung H, Dai T, Sharma SK, Huang YY, Carroll JD, Hamblin MR. The nuts and bolts of low-level laser (light) therapy. Ann Biomed Eng. 2012; 40(2): 516-33[DOI][PubMed]
  • 13. Hamblin MR, Demidova TN. Mechanisms of low level light therapy Proc 2006;
  • 14. Allen KD, Golightly YM. State of the evidence. Curr Opin Rheumatol. 2015; 27(3): 276-83[DOI][PubMed]
  • 15. Neogi T, Zhang Y. Epidemiology of osteoarthritis. Rheum Dis Clin North Am. 2013; 39(1): 1-19[DOI][PubMed]
  • 16. Parmelee PA, Tighe CA, Dautovich ND. Sleep disturbance in osteoarthritis: linkages with pain, disability, and depressive symptoms. Arthritis Care Res (Hoboken). 2015; 67(3): 358-65[DOI][PubMed]
  • 17. Wheaton M, Jensen N. The ligament injury connection to osteoarthritis (extended version). J Prolo. 2011; 3(4)
  • 18. Kean WF, Kean R, Buchanan WW. Osteoarthritis: symptoms, signs and source of pain. Inflammopharmacology. 2004; 12(1): 3-31[DOI][PubMed]
  • 19. Alderman D. Prolotherapy for knee pain. Pract Pain Manag. 2007; 7(6): 70-9
  • 20. Fishman SM. Opioid side effects, addiction, and anti-inflammatory medications. J Pain Palliat Care Pharmacother. 2005; 19(1): 51-5[DOI][PubMed]
  • 21. Fishbain DA, Cole B, Lewis J, Rosomoff HL, Rosomoff RS. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med. 2008; 9(4): 444-59[DOI][PubMed]
  • 22. Gomes T. Opioid Crisis should be on top of federal health agenda. Hospital News. 2016;
  • 23. Wallace G. Tackling the misuse of opioids; safe prescribing. Hospital News. 2016;
  • 24. Topol GA, Podesta LA, Reeves KD, Giraldo MM, Johnson LL, Grasso R, et al. Chondrogenic Effect of Intra-articular Hypertonic-Dextrose (Prolotherapy) in Severe Knee Osteoarthritis. PM R. 2016; 8(11): 1072-82[DOI][PubMed]
  • 25. Bertram KL, Krawetz RJ. Osmolarity regulates chondrogenic differentiation potential of synovial fluid derived mesenchymal progenitor cells. Biochem Biophys Res Commun. 2012; 422(3): 455-61[DOI][PubMed]
  • 26. Rabago D, Patterson JJ. Prolotherapy: an effective adjunctive therapy for knee osteoarthritis. J Am Osteopath Assoc. 2013; 113(2): 122-3[PubMed]
  • 27. Tumilty SJ. Low level laser therapy for the treatment of tendinopathy with emphasis on the achilles tendon. 2010;
  • 28. Scarpone M, Rabago DP, Zgierska A, Arbogast G, Snell E. The efficacy of prolotherapy for lateral epicondylosis: a pilot study. Clin J Sport Med. 2008; 18(3): 248-54[DOI][PubMed]
  • 29. Schneider C. Traumeel - an emerging option to nonsteroidal anti-inflammatory drugs in the management of acute musculoskeletal injuries. Int J Gen Med. 2011; 4: 225-34[DOI][PubMed]
  • 30. Dagenais S, Ogunseitan O, Haldeman S, Wooley JR, Newcomb RL. Side effects and adverse events related to intraligamentous injection of sclerosing solutions (prolotherapy) for back and neck pain: A survey of practitioners. Arch Phys Med Rehabil. 2006; 87(7): 909-13[DOI][PubMed]
  • 31. Dagenais S, Yelland MJ, Del Mar C, Schoene ML. Prolotherapy injections for chronic low-back pain. Cochrane Database Syst Rev. 2007; (2)[DOI][PubMed]
  • 32. Hayden JA, van Tulder MW, Malmivaara AV, Koes BW. Meta-analysis: exercise therapy for nonspecific low back pain. Ann Intern Med. 2005; 142(9): 765-75[PubMed]
  • 33. Schneiders AG, Zusman M, Singer KP. Exercise therapy compliance in acute low back pain patients. Man Ther. 1998; 3(3): 147-52[DOI]
  • 34. Conlan MJ, Rapley JW, Cobb CM. Biostimulation of wound healing by low-energy laser irradiation. A review. J Clin Periodontol. 1996; 23(5): 492-6[DOI][PubMed]
  • 35. Gur A, Sarac AJ, Cevik R, Altindag O, Sarac S. Efficacy of 904 nm gallium arsenide low level laser therapy in the management of chronic myofascial pain in the neck: a double-blind and randomize-controlled trial. Lasers Surg Med. 2004; 35(3): 229-35[DOI][PubMed]
  • 36. Baltzer AW, Ostapczuk MS, Stosch D. Positive effects of low level laser therapy (LLLT) on Bouchard's and Heberden's osteoarthritis. Lasers Surg Med. 2016; 48(5): 498-504[DOI][PubMed]
  • 37. Karu TI. Multiple roles of cytochrome c oxidase in mammalian cells under action of red and IR-A radiation. IUBMB Life. 2010; 62(8): 607-10[DOI][PubMed]
  • 38. Bjordal JM, Johnson MI, Iversen V, Aimbire F, Lopes-Martins RA. Low-level laser therapy in acute pain: a systematic review of possible mechanisms of action and clinical effects in randomized placebo-controlled trials. Photomed Laser Surg. 2006; 24(2): 158-68[DOI][PubMed]
  • 39. Almeida-Lopes L, Rigau J, Zangaro RA, Guidugli-Neto J, Jaeger MM. Comparison of the low level laser therapy effects on cultured human gingival fibroblasts proliferation using different irradiance and same fluence. Lasers Surg Med. 2001; 29(2): 179-84[DOI][PubMed]
  • 40. Bjordal JM, Lopes-Martins RA, Iversen VV. A randomised, placebo controlled trial of low level laser therapy for activated Achilles tendinitis with microdialysis measurement of peritendinous prostaglandin E2 concentrations. Br J Sports Med. 2006; 40(1): 76-80[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments